Monoclonal Gammopathy of Undetermined Significance Clinical Trials
2 recruiting trials for Monoclonal Gammopathy of Undetermined Significance. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT05136807
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
This study examines the quality of life in patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma. Collecting quality of life information from...
Sponsor: M.D. Anderson Cancer CenterEnrolling: 4001 location
RECRUITINGNCT01408225
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
The investigators are researching patients with diseases of their plasma cells in order to improve their quality and length of life. The investigators have created a database of...
Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 50001 location